Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.

Rybarczyk-Kasiuchnicz, Agnieszka; Ramlau, Rodryg; Stencel, Katarzyna

Rybarczyk-Kasiuchnicz, Agnieszka; Ramlau, Rodryg; Stencel, Katarzyna.

Affiliation

Rybarczyk-Kasiuchnicz A; Department of Chemotherapy, Poznan University of Medical Sciences, Clinical Hospital of Lord Transfiguration, 61-848 Poznan, Poland.
Ramlau R; Department of Chemotherapy, Poznan University of Medical Sciences, Clinical Hospital of Lord Transfiguration, 61-848 Poznan, Poland.
Stencel K; Department of Chemotherapy, Poznan University of Medical Sciences, Clinical Hospital of Lord Transfiguration, 61-848 Poznan, Poland.

Int J Mol Sci ; 22(2)2021 Jan 08.

Article in En | MEDLINE | ID: mdl-33435596

Subject(s)

Brain Neoplasms/drug therapy; Carcinoma, Non-Small-Cell Lung/drug therapy; Drug Resistance, Neoplasm/drug effects; Lung Neoplasms/drug therapy; Protein Kinase Inhibitors/therapeutic use; Acrylamides/therapeutic use; Aniline Compounds/therapeutic use; Brain Neoplasms/genetics; Brain Neoplasms/secondary; Carcinoma, Non-Small-Cell Lung/genetics; Carcinoma, Non-Small-Cell Lung/pathology; Drug Resistance, Neoplasm/genetics; ErbB Receptors/antagonists & inhibitors; ErbB Receptors/genetics; ErbB Receptors/metabolism; Humans; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Mutation; Pyrimidines/therapeutic use; Sulfones/therapeutic use

Key words

ALK; EGFR; brain metastases; immunotherapy; non-small cell lung carcinoma; treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google